Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Sucrose ester-C20 to C28 alcohol formulations|
|Abstract:||A stable, efficacious therapeutic cream wherein a principal therapeutic compounds are one or more C-20 to C-28 long chain aliphatic alcohols, of which n-docosanol is exemplary, comprising sucrose cocoate, sucrose stearates or sucrose distearate, or mixtures thereof, is disclosed.|
|Inventor(s):||Katz; David H. (La Jolla, CA), Khalil; Mohammed H. (San Diego, CA), Marcelletti; John F. (San Diego, CA), Pope; Laura E. (Carlsbad, CA), Katz; Lee R. (La Jolla, CA)|
|Assignee:||Lidak Pharmaceuticals (La Jolla, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Compound; Composition; Formulation;|
|Country||Document Number||Publication Date|
|European Patent Office||1473031||Nov 03, 2004|
|European Patent Office||0738141||Oct 23, 1996|
|World Intellectual Property Organization (WIPO)||9516434||Jun 22, 1995|
|Denmark||1473031||Oct 20, 2008|
|Singapore||43833||Nov 14, 1997|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.